A carregar...
hiPSC‐derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine
Mesenchymal stem cells (MSCs) are being assessed for ameliorating the severity of graft‐versus‐host disease, autoimmune conditions, musculoskeletal injuries and cardiovascular diseases. While most of these clinical therapeutic applications require substantial cell quantities, the number of MSCs that...
Na minha lista:
| Publicado no: | J Cell Mol Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4956943/ https://ncbi.nlm.nih.gov/pubmed/27097531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12839 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|